On Draper Startup Sounds, Gerónimo “Jero” Diosque, founder & CEO of New Organs Biotech, explains how his team is building precision immunomonitoring to predict transplant rejection earlier—so patients keep their grafts longer with fewer invasive procedures
We cover Jero’s leap from industrial engineering to biotech, the GridX company-builder journey, what a lab-grown ex vivo organ/tissue model actually means, and why disciplined execution (not just pitch days) is the real founder job.
